Catch me if you can: SARS-CoV-2 detection in brains of deceased patients with COVID-19.
Catch me if you can: SARS-CoV-2 detection in brains of deceased patients with COVID-19.
复制标题
DOI:
10.1016/s1474-4422(20)30371-9
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Frank S
中科院分区:
文献类型:
--
作者:
Frank S
In the American biographical crime film Catch Me If You Can, FBI agent Carl Hanratty goes all out to catch the notorious impostor and cheque counterfeiter Frank Abagnale Jr. Hanratty’s dogged pursuit of the culprit bears striking resemblance to current COVID19 research efforts to find evidence of changes that severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection might leave in the brain. In The Lancet Neurology, Jakob Matschke and colleagues1 give a detailed account of the histological alterations related to COVID19 in the CNS. Through meticulous detective work, they mapped the brain’s immunoinflammatory response to viral infection and detected SARSCoV2 protein expression in a substantial percentage of autoptic brains of patients with COVID19. Matschke and colleagues analysed 43 brains from a large cohort of patients who died with COVID19, 2 focusing on inflammatory changes and detection of SARSCoV2. To find out which CNS cell types are prone to SARSCoV2 infection, the authors screened gene expression datasets for signatures related to viral entry and persistence. Their insilico analysis showed high expres sion of angiotensinconverting enzyme 2 (ACE2) in oligodendrocytes and of transmembrane serine pro teases 2 and 4 (TMPRSS2 and TMPRSS4) in neurons—genes that code for proteins crucially implicated in SARS CoV2 hostcell entry (ACE2) and proteolytic priming of the virusdecorating spikes (TMPRSS2). 3 Interestingly, a study using human brain organoids, published in September, 2020, 4 showed that SARSCoV2 can readily infect and kill neurons. The neuronal cell death upon viral infec tion was preceded by aberrant intraneuronal localisa tion and hyperphosphorylation of Tau protein, 4 similar to the pathogenesis of Alzheimer’s disease and other neuro degenerative diseases.Matschke and colleagues used quantitative RTPCR (qRTPCR) and immunohistochemistry with antibodies against nucleocapsid and spike proteins to detect SARSCoV2. Whereas viral RNA was detected in 48% of cases, viral protein detection was positive in 40%. Overall, the authors found SARSCoV2, either viral RNA or viral protein (or both), in 51% of the brains investi gated. Remarkably, SARSCoV2 presence did not correlate with the severity of neuropathological alterations. While the